Daewon Pharmaceutical Co. Ltd. (003220) — Tangible Net Worth Ratio
Daewon Pharmaceutical Co. Ltd. (003220) has a Tangible Net Worth Ratio of 76.3% as of June 2026. This metric is calculated by deducting intangible assets (₩65.46 Billion) from net assets (₩275.73 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore net asset momentum of Daewon Pharmaceutical Co. Ltd. to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Daewon Pharmaceutical Co. Ltd. Tangible Net Worth Ratio (2011–2025)
This chart shows how Daewon Pharmaceutical Co. Ltd.'s Tangible Net Worth Ratio has changed across 15 annual periods from 2011 to 2025. As of June 2026, the ratio stands at 76.3%, reflecting net assets of ₩275.73 Billion with intangible assets of ₩65.46 Billion KRW. Check asset allocation strategy of Daewon Pharmaceutical Co. Ltd. to assess the company's strategic physical and investment asset allocation.
Annual Tangible Net Worth Ratio for Daewon Pharmaceutical Co. Ltd. (2011–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for Daewon Pharmaceutical Co. Ltd. from 2011 to 2025, covering 15 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For live market cap and overall valuation, see Daewon Pharmaceutical Co. Ltd. market cap and net worth.
| Year | Tangible NW Ratio | Net Assets (KRW) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 79.4% | ₩274.58 Billion | ₩56.48 Billion | ₩613.65 Billion | ▼ -3.3 pp |
| 2024 | 82.7% | ₩284.58 Billion | ₩49.15 Billion | ₩583.39 Billion | ▼ -4.3 pp |
| 2023 | 87.1% | ₩264.26 Billion | ₩34.22 Billion | ₩508.00 Billion | ▼ -1.4 pp |
| 2022 | 88.4% | ₩248.77 Billion | ₩28.74 Billion | ₩453.55 Billion | ▲ +1.7 pp |
| 2021 | 86.8% | ₩218.40 Billion | ₩28.89 Billion | ₩429.58 Billion | ▼ -2.2 pp |
| 2020 | 89.0% | ₩212.77 Billion | ₩23.43 Billion | ₩335.21 Billion | ▼ -1.1 pp |
| 2019 | 90.1% | ₩204.22 Billion | ₩20.22 Billion | ₩327.53 Billion | ▲ +0.3 pp |
| 2018 | 89.8% | ₩183.20 Billion | ₩18.68 Billion | ₩275.44 Billion | ▼ -2.1 pp |
| 2017 | 91.9% | ₩168.13 Billion | ₩13.68 Billion | ₩227.20 Billion | ▼ -2.4 pp |
| 2016 | 94.2% | ₩162.01 Billion | ₩9.32 Billion | ₩214.68 Billion | ▼ -3.9 pp |
| 2015 | 98.1% | ₩148.66 Billion | ₩2.78 Billion | ₩194.75 Billion | ▲ +1.2 pp |
| 2014 | 97.0% | ₩134.51 Billion | ₩4.09 Billion | ₩180.62 Billion | ▲ +0.8 pp |
| 2013 | 96.2% | ₩123.25 Billion | ₩4.74 Billion | ₩160.14 Billion | ▲ +1.1 pp |
| 2012 | 95.1% | ₩112.92 Billion | ₩5.58 Billion | ₩147.13 Billion | ▲ +0.7 pp |
| 2011 | 94.4% | ₩103.92 Billion | ₩5.84 Billion | ₩140.39 Billion | — |